UCLA researchers to study prostate cancer drug for Covid-19
Degarelix is a hormone suppresser and is expected to help improve clinical outcomes for men with Covid-19. Credit: Gerd Altmann from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
